R
Retina and Vitreous of Texas, PLLC | Houston, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ranibizumab
Triamcinolone Acetonide
-Ranibizumab
Ranibizumab
Ranibizumab+Deferred
Zimura
JNJ-81201887
Bevacizumab
Razuprotafib
Abicipar Pegol
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 19 total trials
The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.
Enrolling
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure
Trial sponsors
C
E
I
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems